(S1 (S (S (NP (NP (NNS Transfections)) (CC and) (NP (NN reporter) (NN gene) (NNS assays)))) (. .)))
(S1 (S (S (NP (NN T) (NNS cells)) (VP (VBD were) (VP (VBN rested) (PP (IN in) (NP (JJ serum-free) (NN AIM-V) (NN medium) (JJ overnight)))))) (. .)))
(S1 (S (S (NP (NP (CD 3.5) (NN microg)) (PP (IN of) (NP (NP (DT the) (NN FOXP3) (NN promoter) (NN luciferase) (NN reporter) (NN vector)) (CC or) (NP (NP (DT a) (NN combination)) (PP (ADVP (RB together)) (IN with) (NP (DT the) (NN RUNX1)))) (, ,) (NP (NN RUNX3) (NN pEGFPN1) (NN vector)) (, ,) (CC and) (NP (ADJP (CD 0.5) (NN microg)) (NN phRL-TK))))) (VP (VBD were) (VP (VP (VBN added) (PP (TO to) (NP (NP (QP (CD 3) (CC x) (CD 106)) (JJ CD4+) (NN T) (NNS cells)) (VP (VBN resuspended) (PP (IN in) (NP (NP (CD 100) (NN microl)) (PP (IN of) (NP (NP (NN Nucleofector) (NN solution)) (PRN (-LRB- -LRB-) (NP (NN Lonza)) (-RRB- -RRB-)))))))))) (CC and) (VP (VBN electroporated) (S (VP (VBG using) (NP (DT the) (NN program) (NN U-15)))))))) (. .)))
(S1 (S (S (PP (IN After) (NP (NP (DT a) (JJ 24-h) (NN culture)) (PP (IN in) (NP (NP (NP (JJ serum-free) (NNS conditions)) (CC and) (NP (NNS stimuli))) (SBAR (IN as) (S (VP (VBN indicated) (PP (IN in) (NP (DT the) (NNS figures)))))))))) (, ,) (NP (NN luciferase) (NN activity)) (VP (VBD was) (VP (VBN measured) (PP (IN by) (NP (NP (NP (DT the) (JJ dual) (NN luciferase) (NN assay) (NN system)) (PRN (-LRB- -LRB-) (NP (NN Promega)) (-RRB- -RRB-))) (VP (VBG according) (PP (TO to) (NP (NP (DT the) (NN manufacturer) (POS 's)) (NNS instructions))))))))) (. .)))
(S1 (S (S (NP (NN PMA/ionomycin)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB stimulate) (NP (DT the) (NNS cells)))))) (, ,) (SBAR (IN because) (S (S (NP (DT the) (NN transfection)) (VP (VBD was) (ADJP (RB only) (JJ transient)))) (CC and) (S (NP (DT the) (NN luciferase) (NN assay)) (VP (VBD required) (NP (NP (DT a) (ADJP (ADJP (JJ strong)) (CC and) (ADJP (JJ fast))) (NN stimulation)) (PP (IN of) (NP (DT the) (NNS cells)))))))))) (. .)))
(S1 (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NN overexpression)) (PP (IN of) (NP (NP (NN RUNX1)) (CC or) (NP (NN RUNX3)))) (PP (IN on) (NP (NN FOXP3) (NN protein) (NNS levels))))))))) (, ,) (NP (JJ CD4+) (NN T) (NNS cells)) (VP (VBD were) (ADJP (JJ preactivated) (PP (IN with) (NP (NP (ADJP (CD 2) (NN microg/ml)) (NN phytohemagglutinin)) (PRN (-LRB- -LRB-) (NP (NN Sigma-Aldrich)) (-RRB- -RRB-))))) (PP (IN in) (NP (JJ serum-free) (JJ AIM-V) (NN medium))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (CD 1) (NN nmol/liter) (NN IL-2))))) (-LRB- -LRB-) (NP (NNP Roche)) (-RRB- -RRB-) (PP (IN for) (NP (CD 12) (NN h))) (, ,) (CC and) (ADVP (RB then)) (VP (VBN transfected) (PP (IN with) (NP (NP (DT the) (NN vector) (NN pEGFPN1)) (VP (VBG containing) (NP (NP (NP (DT the) (NN RUNX1) (CC or) (NN RUNX3) (NN fragment)) (VP (VBG using) (NP (NP (DT the) (NN Nucleofector) (NN system)) (PRN (-LRB- -LRB-) (NP (NN Amaxa) (NN Biosystems)) (-RRB- -RRB-))))) (CC and) (NP (DT the) (NN program) (NN T-23)))))))) (. .)))
(S1 (S (S (NP (NN FOXP3) (NN expression)) (VP (VBD was) (VP (VBN evaluated) (PP (IN by) (NP (NN flow) (NN cytometry))) (PP (IN after) (NP (NP (CD 48) (NN h)) (PP (IN of) (NP (NN culture))) (PP (IN in) (NP (NP (JJ AIM-V) (NN medium)) (VP (VBG containing) (NP (ADJP (CD 1) (NN nmol/liter)) (NN IL-2)))))))))) (. .)))
